Role of advanced glycation end products (AGE) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy

Department of Internal Medicine III, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan.
International journal of clinical pharmacology research 02/2003; 23(4):129-34.
Source: PubMed


Diabetic vascular complication is a leading cause of acquired blindness, end-stage renal failure, a variety of neuropathies and accelerated atherosclerosis, which could account for disabilities and high mortality rates in patients with diabetes. Chronic hyperglycemia is essentially involved in the pathogenesis of diabetic micro- and macrovascular complications via various metabolic derangements. In this review, we discuss the molecular mechanisms of diabetic retinopathy and nephropathy, especially focusing on advanced glycation end products (AGEs) and their receptor (RAGE) system. Several types of AGE inhibitors and their therapeutic implications in diseases, including diabetic microangiopathy, will be discussed in the next review article.

5 Reads
  • Source
    • "Advanced glycation end products (AGEs) result from the Maillard reaction, which is a non-enzymatic, irreversible process (1). Some studies suggest that AGEs accelerate atherosclerosis in type-2 diabetic patients with coronary heart disease (2,3). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Advanced glycation end products (AGEs) play an important role in the proliferation of vascular smooth muscle cells (VSMCs) and accelerate atherosclerosis in diabetic patients. Autophagy, a life-sustaining process, is stimulated in atherosclerotic plaques by oxidized lipids, inflammation and metabolic stress conditions. In our studies, we utilized MTT assays to show that autophagy is involved in AGE-induced proliferation of VSMCs. Furthermore, treatment with AGEs (100 µg/ml) could induce autophagy in a time- and dose-dependent manner in rat aortic VSMCs. These results were further substantiated by electron microscopy and immunofluorescence imaging. Treatment with AGEs activated ERK, JNK and p38/MAPK, but inhibited Akt. Pretreatment with an ERK inhibitor and an Akt activator inhibited AGE-induced autophagy, demonstrating that AGEs induce autophagy in VSMCs through the ERK and Akt signaling pathways. In addition, RNA interference of RAGE decreased autophagy, indicating that RAGE is pivotal in the process of AGE-induced autophagy. Therefore, AGE-induced autophagy contributes to the process of AGE-induced proliferation of VSMCs, which is related to atherosclerosis in diabetes.
    International Journal of Molecular Medicine 04/2012; 29(4):613-8. DOI:10.3892/ijmm.2012.891 · 2.09 Impact Factor
  • Source
    • "GA is an Amadori product formed non-enzymatically through the condensation reaction of glucose with reactive proteins under conditions of hyperglycemia [2,3]. Amadori products undergo further irreversible reactions to yield advanced glycation end-products (AGEs) [4,5]. Thus, Amadori products are formed through a reversible process that depends on the level of glycemia, whereas AGEs are produced irreversibly and are strong inducers of inflammation [6]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Glycated albumin (GA) is an Amadori product used as a marker of hyperglycemia. In this study, we investigated the effect of GA on insulin secretion from pancreatic β cells. Islets were collected from male Wistar rats by collagenase digestion. Insulin secretion in the presence of non-glycated human albumin (HA) and GA was measured under three different glucose concentrations, 3 mM (G3), 7 mM (G7), and 15 mM (G15), with various stimulators. Insulin secretion was measured with antagonists of inducible nitric oxide synthetase (iNOS), and the expression of iNOS-mRNA was investigated by real-time PCR. Insulin secretion in the presence of HA and GA was 20.9 ± 3.9 and 21.6 ± 5.5 μU/3 islets/h for G3 (P = 0.920), and 154 ± 9.3 and 126.1 ± 7.3 μU/3 islets/h (P = 0.046), for G15, respectively. High extracellular potassium and 10 mM tolbutamide abrogated the inhibition of insulin secretion by GA. Glyceraldehyde, dihydroxyacetone, methylpyruvate, GLP-1, and forskolin, an activator of adenylate cyclase, did not abrogate the inhibition. Real-time PCR showed that GA did not induce iNOS-mRNA expression. Furthermore, an inhibitor of nitric oxide synthetase, aminoguanidine, and NG-nitro-L-arginine methyl ester did not abrogate the inhibition of insulin secretion. GA suppresses glucose-induced insulin secretion from rat pancreatic β-cells through impairment of intracellular glucose metabolism.
    Nutrition & Metabolism 04/2011; 8(1):20. DOI:10.1186/1743-7075-8-20 · 3.26 Impact Factor
  • Source
    • "RAGE mediates physiological and pathological effects through interaction with a diverse set of ligands, which remarkably , are each associated with a specific disease. The first identified RAGE ligand was advanced glycation end products (AGEs), which form by nonenzymatic glycation of proteins and lipids and accumulate as a result of normal aging and inflammatory processes, particularly in diabetes (Yamagishi et al., 2003). RAGE is up-regulated in Alzheimer disease, and soluble amyloid-b has been shown to bind to the receptor inducing oxidative stress in neurons and the production of proinflammatory cytokines in microglia (Yan et al., 2003). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The receptor for advanced glycation end products (RAGE) is a pattern recognition receptor involved in inflammatory processes and is associated with diabetic complications, tumor outgrowth, and neurodegenerative disorders. RAGE induces cellular signaling events upon binding of a variety of ligands, such as glycated proteins, amyloid-β, HMGB1, and S100 proteins. The X-ray crystal structure of the VC1 ligand-binding region of the human RAGE ectodomain was determined at 1.85 Å resolution. The VC1 ligand-binding surface was mapped onto the structure from titrations with S100B monitored by heteronuclear NMR spectroscopy. These NMR chemical shift perturbations were used as input for restrained docking calculations to generate a model for the VC1-S100B complex. Together, the arrangement of VC1 molecules in the crystal and complementary biochemical studies suggest a role for self-association in RAGE function. Our results enhance understanding of the functional outcomes of S100 protein binding to RAGE and provide insight into mechanistic models for how the receptor is activated.
    Structure 10/2010; 18(10):1342-52. DOI:10.1016/j.str.2010.05.017 · 5.62 Impact Factor
Show more